Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-174447
Filing Date
2025-08-06
Accepted
2025-08-06 16:06:03
Documents
15
Effectiveness Date
2025-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 d20231ds8.htm S-8 65592
2 EX-5.1 d20231dex51.htm EX-5.1 6250
3 EX-23.2 d20231dex232.htm EX-23.2 1321
4 EX-FILING FEES d20231dexfilingfees.htm   iXBRL EX-FILING FEES 71493
5 GRAPHIC g20231g73i20.jpg GRAPHIC 2791
  Complete submission text file 0001193125-25-174447.txt   351771

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d20231dexfilingfees_htm.xml XML 37760
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289291 | Film No.: 251189496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)